The PROTECT AF (WATCHMAN Left Atrial Appendage System for embolic PROTECTion in patients with atrial fibrillation) trial
The PROTECT AF (WATCHMAN Left Atrial Appendage System for embolic PROTECTion in patients with atrial fibrillation) trial
复制标题
DOI：
10.1016/j.ahj.2006.02.005
复制
发表时间：
2006-05-01
影响因子：
4.8
通讯作者：
Turi, Z
中科院分区：
文献类型：
--
作者：
Fountain, RB;Holmes, DR;Turi, Z
Protect AF试验是经皮左心耳隔离器械的唯一随机试验。本试验的重点是评价这种器械与华法林标准治疗的相对优点。
The Protect AF trial is the only randomized trial of a percutaneous LAA isolation device. This trial is focused on evaluation of the relative merits of such a device versus standard therapy with warfarin.